Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kezar Life Sciences Inc (NQ: KZR ) 0.6301 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Kezar Life Sciences Inc < Previous 1 2 3 Next > Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) July 10, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) June 07, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference May 29, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 06, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) April 08, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update March 14, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) March 08, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference February 28, 2024 From Kezar Life Sciences, Inc. Via Business Wire Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis February 26, 2024 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update November 13, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) November 03, 2023 From Kezar Life Sciences, Inc. Via Business Wire 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis October 23, 2023 Via ACCESSWIRE Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) October 09, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer October 03, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia September 20, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Participate in Three Upcoming Investor Conferences August 31, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update August 10, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) August 04, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) July 07, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) June 09, 2023 From Kezar Life Sciences Via Business Wire Kezar Life Sciences to Participate in the Jefferies Healthcare Conference May 31, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update May 11, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) April 05, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update March 14, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Change Virtual R&D Day Date to March 15, 2023 March 13, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023 March 06, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) March 03, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference March 01, 2023 From Kezar Life Sciences, Inc. Via Business Wire Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) February 06, 2023 From Kezar Life Sciences, Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.